Form 4 for ASTH Astrana Health, Inc.
Accepted 2026-09-08 16:41:16 ET · period of report 2026-09-05 · accession 0001104659-26-105932 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 16:41 | 2026-09-05 | ASTH | Basho Chandan | COO, CFO | F - Tax | $38.47 | -1,790 | 157.8K | -1% | -$68.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-05 | F | D | 1,790 | $38.47 | 157,820 | D | — | — | (F1) Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2026. (F2) Includes 15,202 shares of unvested restricted stock which will vest on May 16, 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 16,690 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027. |